Nanoform Finland
1.15 EUR
-2.54 %
3,669 following
NANOFH
First North Finland
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-2.54 %
-1.88 %
+16.40 %
-6.50 %
+5.70 %
-19.01 %
-63.32 %
-83.05 %
-77.23 %
Nanoform Finland operates in the medical technology sector. The company specializes in research and development of nanoparticle technology used to create nanoparticles in pharmaceuticals. The technology is used as a complement in the production process and is used for the treatment of diseases such as ALS and Alzheimer's. Customers consist of players in the global pharmaceutical industry, with the largest operations in the Nordic market. Nanoform Finland is headquartered in Helsinki.
Read moreMarket cap
98.52M EUR
Turnover
208.9K EUR
Revenue
2.78M
EBIT %
-872.43 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
26.2
2026
Annual report '25
14.4
2026
General meeting '26
19.5
2026
Interim report Q1'26
All
Research
Webcasts
Press releases
ShowingAll content types
Life Science Companies as Investments | Life Science Night Dec. 9, 2025
Inside information: Nanoform announces new midterm business targets for 2030
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools